PrairieView Partners’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$0 Hold
13
﹤0.01% 384
2025
Q1
$0 Hold
13
﹤0.01% 380
2024
Q4
$0 Hold
13
﹤0.01% 380
2024
Q3
$0 Hold
13
﹤0.01% 402
2024
Q2
$0 Hold
13
﹤0.01% 394
2024
Q1
$1K Hold
13
﹤0.01% 373
2023
Q4
$0 Hold
13
﹤0.01% 404
2023
Q3
$0 Hold
13
﹤0.01% 452
2023
Q2
$0 Hold
13
﹤0.01% 469
2023
Q1
$0 Hold
13
﹤0.01% 472
2022
Q4
$0 Hold
13
﹤0.01% 488
2022
Q3
$0 Sell
13
-10
-43% -$302 ﹤0.01% 461
2022
Q2
$1K Buy
23
+10
+77% +$350 ﹤0.01% 437
2022
Q1
$0 Hold
13
﹤0.01% 475
2021
Q4
$0 Hold
13
﹤0.01% 432
2021
Q3
$0 Hold
13
﹤0.01% 383
2021
Q2
$0 Buy
+13
New +$428 ﹤0.01% 372

Other funds holding OGN

PrairieView Partners's OGN Position: Q2 2025 in Review

PrairieView Partners held its Organon & Co (OGN) position steady in Q2 2025 at 13 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #384.

PrairieView Partners first reported a position in OGN in Q2 2021 and has held it in 17 quarters since. The position peaked at $1K in Q1 2024. 694 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • PrairieView Partners held 13 shares of Organon & Co worth $0 as of Q2 2025.
  • PrairieView Partners left its Organon & Co share count unchanged in Q2 2025.
  • Organon & Co made up ﹤0.01% of PrairieView Partners's portfolio in Q2 2025, its #384 holding.
  • PrairieView Partners first reported a position in Organon & Co in Q2 2021 and has held it in 17 quarters since.
  • PrairieView Partners's Organon & Co position peaked at $1K in Q1 2024.
  • 694 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on PrairieView Partners's 13F filing for Q2 2025, filed 25 Jul 2025.